Related Experiment Video

Updated: Mar 18, 2026

A Guide to Production, Crystallization, and Structure Determination of Human IKK1/α
11:27

A Guide to Production, Crystallization, and Structure Determination of Human IKK1/α

Published on: November 2, 2018

9.6K

Non-canonical NF-κB Plays a Pivotal Role in Non-Hodgkin's Lymphoma

Mingge Liu1, Wei Song1, Jianbo Zhang1

  • 1Department of Pathology, Affiliated Cancer Hospital of Zhengzhou University, Henan Provincial Cancer Hospital, Zhengzhou, 450003, China.

Cell Biochemistry and Biophysics
|June 29, 2016
PubMed

Insights

This study reveals that higher levels of BAFF/BAFF-R signaling correlate with drug resistance in B-cell non-Hodgkin's lymphoma. These findings suggest a role for non-canonical NF-κB signaling in lymphoma treatment failure.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • B-cell non-Hodgkin's lymphoma (NHL) poses significant treatment challenges, with drug resistance being a major factor in therapeutic failure.
  • The role of B-cell activating factor (BAFF) and its receptor (BAFF-R) in non-canonical NF-κB signaling pathways remains incompletely understood in the context of lymphoma drug resistance.

Purpose of the Study:

  • To investigate the involvement of BAFF/BAFF-R-mediated non-canonical NF-κB signaling in the development of drug resistance in B-cell non-Hodgkin's lymphoma.
  • To correlate gene expression levels of BAFF, BAFF-R, Bcl-xL, and RIPK2 with drug resistance and disease progression in B-cell NHL patients.

Main Methods:

  • FQ-PCR was used to quantify mRNA expression of BAFF, BAFF-R, Bcl-xL, and RIPK2 in patient blood and tumor tissues.
  • MTT assays assessed the impact of BAFF on lymphoma cell proliferation.
  • Western blot analysis determined protein expression levels following BAFF stimulation.

Main Results:

  • Significantly higher mRNA expression of BAFF, BAFF-R, Bcl-xL, and RIPK2 was observed in the circulating blood of drug-resistant B-cell NHL patients compared to non-resistant patients.
  • mRNA expression of these target genes positively correlated with each other and with disease progression.
  • Increased BAFF concentration and exposure significantly enhanced lymphoma cell proliferation and upregulated the expression of BAFF, BAFF-R, Bcl-xL, and RIPK2 proteins.

Conclusions:

  • BAFF/BAFF-R signaling, potentially through non-canonical NF-κB pathways, plays a crucial role in mediating drug resistance in B-cell non-Hodgkin's lymphoma.
  • Elevated BAFF and BAFF-R expression in circulating blood may serve as potential biomarkers for drug resistance in B-cell NHL.
  • Targeting the BAFF/BAFF-R pathway could represent a novel therapeutic strategy to overcome drug resistance in B-cell NHL.
Keywords:
BAFFNF-κB signalingNon-Hodgkin’s lymphoma

More Related Videos

NF-κB-dependent Luciferase Activation and Quantification of Gene Expression in Salmonella Infected Tissue Culture Cells10:57

NF-κB-dependent Luciferase Activation and Quantification of Gene Expression in Salmonella Infected Tissue Culture Cells

Published on: January 12, 2020

11.3K
A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia09:52

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia

Published on: December 4, 2018

8.2K

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.2K
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

2.4K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.1K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
8.6K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

1.8K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
9.2K